Amexdrug (AXRX) Stock Statistics & Valuation Metrics
Total Valuation
Amexdrug has a market cap or net worth of $33.88K. The enterprise value is $41.22T.
- Market Cap
- $33.88K
- Enterprise Value
- $41.22T
Share Statistics
Amexdrug has 169,410,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 169,410,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Amexdrug’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 8.85%.
- Return on Equity (ROE)
- 0.14
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 8.85%
- Return on Capital Employed (ROCE)
- 0.27
- Revenue Per Employee
- 1.16M
- Profits Per Employee
- 12.37K
- Employee Count
- 9
- Asset Turnover
- 4.51
- Inventory Turnover
- 6.89
Income Statement
In the last 12 months, Amexdrug had revenue of 10.43M and earned 111.36K in profits. Earnings per share was 0.00.
- Revenue
- 10.43M
- Gross Profit
- 1.96M
- Operating Income
- 214.62K
- Pretax Income
- 168.14K
- Net Income
- 111.36K
- EBITDA
- 226.81K
- Earnings Per Share (EPS)
- 0.00
Stock Price Statistics
- Beta
- -0.91
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.16
- 200-Day Moving Average
- 0.16
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Amexdrug as a current ratio of 1.50, with Debt / Equity ratio of 99.13%
- Current Ratio
- 1.50
- Quick Ratio
- 0.68
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- 2.49
- Interest Coverage Ratio
- 4.19
Taxes
In the past 12 months, Amexdrug has paid 56.77K in taxes.
- Income Tax
- 56.77K
- Effective Tax Rate
- 0.34
Analyst Forecast
The average price target for Amexdrug is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- -10.54%
- EPS Growth Forecast
- ―